mFOLFIRINOX Treatment Regimen trials for Pancreatic cancer

All mFOLFIRINOX Treatment Regimen trials · All Pancreatic cancer trials

Phase breakdown

Recruiting trials studying mFOLFIRINOX Treatment Regimen for Pancreatic cancer

• DOVIPA, a Study Evaluating Efficacy and Safety of DOstarlimab and VItamin D3 With mFOLFIRINOX in PAncreatic Cancer
  NCT06757244 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 5 locations
• PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples
  NCT04683315 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• To Evaluate the Safety, Tolerability, and Preliminary Efficacy of XH001 Injection as Adjuvant Therapy in Patients With High-risk Recurrent Solid Tumors
  NCT07594964 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 2 locations

Common questions

How many trials study mFOLFIRINOX Treatment Regimen for Pancreatic cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.